Q1 2014's Top Pharma & Biotech M&A Deals

Pharma IQ
Posted: 05/29/2014

The global pharmaceuticals industry has witnessed significant change in the last few years from patent expiry to declining product pipelines. In addition the cost of developing and marketing a new drug continues to soar. One way pharmaceutical and biotech companies are dealing with these challenges is by turning to mergers and acquisitions as a

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Pharma IQ
Posted: 05/29/2014

Pharma IQ Members


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018